Vascular endothelial growth factor (VEGF) increases production, migration and survival of neural stem cells during hypoxia and ischemia

Keyphrases

• Ischemia 100%
• Hypoxia 100%
• Vascular Endothelial Growth Factor 100%
• Neural Stem Cells 100%
• Production Increase 100%
• Neurogenesis 45%
• Subventricular Zone 36%
• Apoptosis 27%
• Cerebral Ischemia 27%
• Growth Factors 27%
• Overexpression 18%
• Improved Outcomes 18%
• Phosphoinositide 3-kinase (PI3K) 18%
• Hypoxic Condition 18%
• Transient Middle Cerebral Artery Occlusion (tMCAO) 18%
• Adult Brain 18%
• Adaptive Response 18%
• Cell Proliferation 9%
• Hypoxic-ischemic Brain Injury 9%
• Neuroprotective Effect 9%
• Neuroprotection 9%
• Therapeutic Target 9%
• Transgenic Mice 9%
• Phosphorylation 9%
• Ischemic Injury 9%
• Overexpressing 9%
• Outcome after Stroke 9%
• Immunostaining 9%
• Angiogenesis 9%
• Cortical Neurons 9%
• Mouse Brain 9%
• Neuropathology 9%
• Newborn Neurons 9%
• Neuronal Cells 9%
• Bromodeoxyuridine 9%
• Infarct Volume 9%
• Cortex 9%
• Dentate Gyrus 9%
• Trophic Factors 9%
• Motor Function 9%
• Brain Repair 9%
• Type-specific 9%
• Specific Marker 9%
• Stem Cell Proliferation 9%
• Induced Growth 9%
• Peri-infarct 9%
• Acute Phase 9%
• Wortmannin 9%
• Neuroblast 9%
• Stem Cell Survival 9%
• Neuron-specific Enolase 9%
• P44/p42 MAP Kinase 9%
• Physiological Stimuli 9%
• VEGF165 9%

Neuroscience

• Vascular Endothelial Growth Factor 100%
• Neural Stem Cell 100%
• Ischemia 100%
• Neurogenesis 45%
• Subventricular Zone 36%
• Brain Ischemia 27%
• Growth Factor 27%
• In Vitro 18%
• Cell Proliferation 18%
• Middle Cerebral Artery 18%
• Adaptive Response 18%
• Phosphoinositide 3-Kinase 18%
• Promoter Region 9%
• In Vivo 9%
• Neuroprotection 9%
• Neuroprotective Agent 9%
• Mitogen-Activated Protein Kinase 9%
• Immunohistochemistry 9%
• Cell Survival 9%
• Dentate Gyrus 9%
• Angiogenesis 9%
• Bromodeoxyuridine 9%
• Wortmannin 9%
• Neuroblast 9%
• Neuron-Specific Enolase 9%
• Cerebrovascular Accident 9%